Company Profile

DiaSorin SpA (OTC: DSRNY)
Pricing data not available
Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): n/a
% Price Change (last 13 weeks): n/a
% Price Change (last 26 weeks): n/a
% Price Change (last 52 weeks): n/a
% Price Change (year to date): n/a
Management Effectiveness
Return on Equity (%): n/a
Return on Assets (%): n/a
Return on Invested Capital (%): n/a
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): n/a
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. The firm specializes in the immunodiagnostics and molecular diagnostics segments. It provides clinical services in the areas like Infectious Diseases, Bone and Mineral, Endocrinology, Hypertension, Oncology, Stool Diagnostics and Autoimmunity. The company was founded in 1968 and is headquartered in Saluggia, Italy.
DiaSorin SpA
Via Crescentino Snc
Saluggia VC 13040

Phone: 39.161.487.1
Fax: n/a
http://www.diasorin.com/
Per Share Data
Earnings (1year) ($): n/a
Annual Dividend ($): n/a
Current P/E Ratio (ttm): n/a
Book Value ($): n/a
Cash Flow ($): n/a
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): n/a
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): n/a
Current Ratio (x): n/a
LT Debt/Equity (x): n/a
Total Debt/Equity (x): n/a



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.